Abstract
BACKGROUND: The peripheral blood concentrations of several proteases of the clotting system have been shown to predict survival in patients with malignancy. A study was undertaken to investigate the independent value of the plasma levels of the D-dimer degradation product of fibrin before treatment for predicting prognosis in patients with lung cancer. METHODS: The study comprised 70 patients with lung cancer (49 non-small cell lung cancer and 21 small cell lung cancer). Plasma levels of D- dimer were measured using an enzyme immunoassay kit. Multivariate statistical analysis was carried out using the Cox's proportional hazards model. RESULTS: The median value of the plasma level of D-dimer differentiated two groups of patients with different outcomes: a group with a D-dimer level of < 150 ng/ml (low DD group) and those with D- dimer levels of > or = 150 ng/ml (high DD group). Survival time was significantly better in patients in the low DD group than in those in the high DD group in all patients (hazard ratio for high DD group = 4.7; 95% confidence interval (CI) 1.8 to 11.7). The plasma levels of D- dimer predicted survival independently from the clinical stage of disease, histological type, performance status, and tumour size (hazard ratio = 3.9; 95% CI 1.6 to 9.2). CONCLUSIONS: These results suggest that plasma levels of D-dimer might be useful for predicting the clinical outcome in patients with lung cancer. However, further prospective studies are needed in a larger population to confirm these findings.
Full Text
The Full Text of this article is available as a PDF (118.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bick R. L. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost. 1992;18(4):353–372. doi: 10.1055/s-2007-1002575. [DOI] [PubMed] [Google Scholar]
- Costantini V., Zacharski L. R. Fibrin and cancer. Thromb Haemost. 1993 May 3;69(5):406–414. [PubMed] [Google Scholar]
- Gabazza E. C., Taguchi O., Yamakami T., Machishi M., Ibata H., Suzuki S. Evaluating prethrombotic state in lung cancer using molecular markers. Chest. 1993 Jan;103(1):196–200. doi: 10.1378/chest.103.1.196. [DOI] [PubMed] [Google Scholar]
- Gasic G. J., Tuszynski G. P., Gorelik E. Interaction of the hemostatic and immune systems in the metastatic spread of tumor cells. Int Rev Exp Pathol. 1986;29:173–212. [PubMed] [Google Scholar]
- Rahman I., Skwarska E., MacNee W. Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease. Thorax. 1997 Jun;52(6):565–568. doi: 10.1136/thx.52.6.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wojtukiewicz M. Z., Zacharski L. R., Moritz T. E., Hur K., Edwards R. L., Rickles F. R. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis. 1992 Aug;3(4):429–437. [PubMed] [Google Scholar]